BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

RELISTOR Pages on BioPortfolio:

Biotechnology News RELISTOR Search
16 Oct 2009 ... Wyeth Quits On Relistor; Surprise Victory in First REMS Test Market So it is not a surprise that Wyeth gave up on Relistor per sebut it is a ...
http://www.bioportfolio.co.uk/RELISTOR-news.htm...

BioPortfolio - - European Medicines Agency (EMEA) Approves ...
has received EMEA marketing approval for Relistor(TM) (methylnaltrexone ... Relistor is now approved for use across all 27 EU member states as well as ...
http://www.bioportfolio.com/news/European_Medicines_Agency_(...

Biotechnology News Progenics Search
RELISTOR was approved last year in single-use vials Related News Entitled to a seven-year period of marketing exclusivity in the US . ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Relistor
MAIDENHEAD, England, July 7 /PRNewswire/ -- Wyeth Pharmaceuticals, today 3rd July, announced that it has received EMEA marketing approval for Relistor(TM)
...
http://www.bioportfolio.com/indepth/Relistor.html...

Biotechnology News Constipation Search
New Delivery System for RELISTOR in Pre-Filled Syringes Submitted for U.S. and ... Relistor (Methylnaltrexone) is a medication for patients who suffer from.
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Relistor - InDepth
Relistor. View the current Relistor InDepth page on BioPortfolio.com (PDF). ( http://www.bioportfolio.com/indepth/Relistor.html) - Regularly Updated. ...
http://www.bioportfolio.com/indepth/Relistor.pdf...

Biotechnology News Hepatitis D Chronic Search
Progenics Regains Worldwide Rights to RELISTOR Franchise Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that it has entered into an
...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

BioPortfolio - Progen Pharmaceuticals - Profile
16 Oct 2009 ... Progenics regains worldwide rights to Relistor franchise from Wyeth ... Wyeth to hand over Relistor, $10M to Progenics ...
http://www.bioportfolio.com/biocorporate/8546-Progen%252BPha...

Biotechnology News SOLODYN Search
Included are Pfizer's cancer treatment Sutent, Wyeth and Progenics Pharmaceuticals' constipation drug Relistor, and Medicis Pharmaceutical's
antibiotic . ...
http://www.bioportfolio.co.uk/SOLODYN-news.htm...

BioPortfolio - Progenics Pharmaceuticals - Profile
Progenics regains worldwide rights to Relistor franchise from Wyeth ... Progenics Pharmaceuticals, Inc. (PGNX) Regains Rights to Relistor from Wyeth (
WYE) ...
http://www.bioportfolio.com/biocorporate/28680-Progenics%252...

Results from other life science and pharmaceutical sites:

RELISTOR® (methylnaltrexone bromide) Subcutaneous Injection
RELISTOR safely and effectively. See full prescribing information for. RELISTOR. ... RELISTOR is administered as a subcutaneous injection. ...
http://www.wyeth.com/content/showlabeling.asp?id=499...

Relistor - DailyMed: About DailyMed
These highlights do not include all the information needed to use RELISTOR safely and effectively. See full prescribing information for RELISTOR. ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=10593...

Mechanism of Action: RELISTOR® (methylnaltrexone bromide ...
RELISTOR is the first agent that targets the underlying cause of opioid-induced constipation (OIC) without impacting opioid-mediated analgesic effects on ...
http://www.wyeth.com/hcp/relistor/mechanism-of-action...

FDA Approves Relistor for Opioid-Induced Constipation
24 Apr 2008 ... The US Food and Drug Administration today approved Relistor (methylnaltrexone bromide) to help restore bowel function in patients with ...
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/20...

RELISTOR® (methylnaltrexone bromide) Efficacy – RelistorHCP.com
Learn more about the efficacy and clinical trial data of RELISTOR.
http://www.wyeth.com/hcp/relistor/efficacy...

Progenics Pharmaceuticals, Inc. Regains Rights to Relistor from ...
14 Oct 2009 ... Progenics will assume full control of future development and commercialization of subcutaneous RELISTOR after a one-year transition, ...
http://www.biospace.com/news_story.aspx?NewsEntityId=159053...

Preparing an Injection of RELISTOR® (methylnaltrexone bromide ...
Gain access to additional content on the RELISTOR Web site and receive updates. You'll also get at no charge, unlimited access to: ...
http://www.wyeth.com/hcp/relistor/injection-video...

Progenics regains rights to Relistor from Wyeth - Yahoo! Finance
14 Oct 2009 ... NEW YORK (AP) -- Progenics Pharmaceuticals Inc. said Wednesday it is regaining the rights to its injectable constipation drug Relistor from ...
http://biz.yahoo.com/ap/091014/us_progenics_pharma_relistor....

RELISTOR® (methylnaltrexone bromide) Dosage and Administration ...
Learn more about RELISTOR dosing and administration.
http://www.wyeth.com/hcp/relistor/dosage-administration...

Methylnaltrexone - Wikipedia, the free encyclopedia
Methylnaltrexone (MNTX, tradename Relistor) is one of the newer agents of .... Relistor is supplied in trays which contain seven one dose vials containing ...
http://en.wikipedia.org/wiki/Methylnaltrexone...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.